Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2464772011 | Conjugated estrogens 0.625mg/medroxyprogesterone acetate 2.5mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2469117018 | Conjugated oestrogens 0.625mg/medroxyprogesterone acetate 2.5mg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 2469591012 | Conjugated estrogens 0.625mg/medroxyprogesterone acetate 2.5mg tablet | en | Synonym (core metadata concept) | Inactive | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 3486736011 | Product containing conjugated estrogens 0.625 mg and medroxyprogesterone acetate 2.5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3495077011 | Product containing conjugated estrogens 0.625 mg and medroxyprogesterone acetate 2.5 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3501920012 | Conjugated estrogens 0.625 mg and medroxyprogesterone acetate 2.5 mg oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3569924014 | Product containing only conjugated estrogens 0.625 mg and medroxyprogesterone acetate 2.5 mg/1 each oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3569925010 | Product containing only conjugated estrogens 0.625 mg and medroxyprogesterone acetate 2.5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699573018 | Conjugated estrogens 625 microgram and medroxyprogesterone 2.5 mg oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699574012 | Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3699575013 | Product containing precisely conjugated estrogens 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3891490011 | Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3891491010 | Conjugated estrogen 625 microgram and medroxyprogesterone 2.5 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Estrogens, conjugated+medroxyprogesterone acetate | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | oestrogeen | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Medroxyprogesterone | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing conjugated estrogen and medroxyprogesterone (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Conjugated estrogen | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Progesterone | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing medroxyprogesterone in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Conjugated estrogen | false | Inferred relationship | Some | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Medroxyprogesterone | false | Inferred relationship | Some | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 2.5 | false | Inferred relationship | Some | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Medroxyprogesterone | false | Inferred relationship | Some | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Medroxyprogesterone | false | Inferred relationship | Some | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 2.5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | Conjugated estrogen | false | Inferred relationship | Some | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Conjugated estrogen | false | Inferred relationship | Some | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 0.625 | false | Inferred relationship | Some | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Product containing conjugated estrogen and medroxyprogesterone in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Conjugated estrogen | false | Inferred relationship | Some | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Medroxyprogesterone | false | Inferred relationship | Some | 2 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator value | 625 | false | Inferred relationship | Some | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit | mcg | false | Inferred relationship | Some | 1 | |
| Product containing precisely conjugated estrogen 625 microgram and medroxyprogesterone 2.5 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Conjugated estrogen and medroxyprogesterone only product in oral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR